Newborn (infant) (liveborn) (singleton)

  • Newborn (infant) (liveborn) (singleton) - Z38.2 Single liveborn infant, unspecified as to place of birth
    • abstinence syndrome - P96.1 Neonatal withdrawal symptoms from maternal use of drugs of addiction
    • acne - L70.4 Infantile acne
    • affected by
      • abnormalities of membranes - P02.9 Newborn affected by abnormality of membranes, unspecified
        • specified NEC - P02.8 Newborn affected by other abnormalities of membranes
      • abruptio placenta - P02.1 Newborn affected by other forms of placental separation and hemorrhage
      • amino-acid metabolic disorder, transitory - P74.8 Other transitory metabolic disturbances of newborn
      • amniocentesis (while in utero) - P00.6 Newborn affected by surgical procedure on mother
      • amnionitis - P02.78 Newborn affected by other conditions from chorioamnionitis
      • apparent life threatening event (ALTE) - R68.13 Apparent life threatening event in infant (ALTE)
      • bleeding (into)
        • cerebral cortex - P52.22 Intraventricular (nontraumatic) hemorrhage, grade 4, of newborn
        • germinal matrix - P52.0 Intraventricular (nontraumatic) hemorrhage, grade 1, of newborn
        • ventricles - P52.1 Intraventricular (nontraumatic) hemorrhage, grade 2, of newborn
      • breech delivery - P03.0 Newborn affected by breech delivery and extraction
      • cardiac arrest - P29.81 Cardiac arrest of newborn
      • cardiomyopathy - I42.8 Other cardiomyopathies
        • congenital - I42.4 Endocardial fibroelastosis
      • cerebral ischemia - P91.0 Neonatal cerebral ischemia
      • Cesarean delivery - P03.4 Newborn affected by Cesarean delivery
      • chemotherapy agents - P04.11 Newborn affected by maternal antineoplastic chemotherapy
      • chorioamnionitis - P02.78 Newborn affected by other conditions from chorioamnionitis
      • cocaine (crack) - P04.41 Newborn affected by maternal use of cocaine
      • complications of labor and delivery - P03.9 Newborn affected by complication of labor and delivery, unspecified
        • specified NEC - P03.89 Newborn affected by other specified complications of labor and delivery
      • compression of umbilical cord NEC - P02.5 Newborn affected by other compression of umbilical cord
      • contracted pelvis - P03.1 Newborn affected by other malpresentation, malposition and disproportion during labor and delivery
      • delivery - P03.9 Newborn affected by complication of labor and delivery, unspecified
        • Cesarean - P03.4 Newborn affected by Cesarean delivery
        • forceps - P03.2 Newborn affected by forceps delivery
        • vacuum extractor - P03.3 Newborn affected by delivery by vacuum extractor [ventouse]
      • drugs of addiction - P04.40 Newborn affected by maternal use of unspecified drugs of addiction
        • cocaine - P04.41 Newborn affected by maternal use of cocaine
        • hallucinogens - P04.42 Newborn affected by maternal use of hallucinogens
        • specified drug NEC - P04.49 Newborn affected by maternal use of other drugs of addiction
      • entanglement (knot) in umbilical cord - P02.5 Newborn affected by other compression of umbilical cord
      • environmental chemicals - P04.6 Newborn affected by maternal exposure to environmental chemical substances
      • fetal (intrauterine)
        • growth retardation - P05.9 Newborn affected by slow intrauterine growth, unspecified
        • inflammatory response syndrome (FIRS) - P02.70 Newborn affected by fetal inflammatory response syndrome
        • malnutrition not light or small for gestational age - P05.2 Newborn affected by fetal (intrauterine) malnutrition not light or small for gestational age
      • FIRS (fetal inflammatory response syndrome) - P02.70 Newborn affected by fetal inflammatory response syndrome
      • forceps delivery - P03.2 Newborn affected by forceps delivery
      • heart rate abnormalities
        • bradycardia - P29.12 Neonatal bradycardia
        • intrauterine - P03.819 Newborn affected by abnormality in fetal (intrauterine) heart rate or rhythm, unspecified as to time of onset
          • before onset of labor - P03.810 Newborn affected by abnormality in fetal (intrauterine) heart rate or rhythm before the onset of labor
          • during labor - P03.811 Newborn affected by abnormality in fetal (intrauterine) heart rate or rhythm during labor
        • tachycardia - P29.11 Neonatal tachycardia
      • hemorrhage (antepartum) - P02.1 Newborn affected by other forms of placental separation and hemorrhage
        • cerebellar (nontraumatic) - P52.6 Cerebellar (nontraumatic) and posterior fossa hemorrhage of newborn
        • intracerebral (nontraumatic) - P52.4 Intracerebral (nontraumatic) hemorrhage of newborn
        • intracranial (nontraumatic) - P52.9 Intracranial (nontraumatic) hemorrhage of newborn, unspecified
          • specified NEC - P52.8 Other intracranial (nontraumatic) hemorrhages of newborn
        • intraventricular (nontraumatic) - P52.3 Unspecified intraventricular (nontraumatic) hemorrhage of newborn
          • grade 1 - P52.0 Intraventricular (nontraumatic) hemorrhage, grade 1, of newborn
          • grade 2 - P52.1 Intraventricular (nontraumatic) hemorrhage, grade 2, of newborn
          • grade 3 - P52.21 Intraventricular (nontraumatic) hemorrhage, grade 3, of newborn
          • grade 4 - P52.22 Intraventricular (nontraumatic) hemorrhage, grade 4, of newborn
        • posterior fossa (nontraumatic) - P52.6 Cerebellar (nontraumatic) and posterior fossa hemorrhage of newborn
        • subarachnoid (nontraumatic) - P52.5 Subarachnoid (nontraumatic) hemorrhage of newborn
        • subependymal - P52.0 Intraventricular (nontraumatic) hemorrhage, grade 1, of newborn
          • with intracerebral extension - P52.22 Intraventricular (nontraumatic) hemorrhage, grade 4, of newborn
          • with intraventricular extension - P52.1 Intraventricular (nontraumatic) hemorrhage, grade 2, of newborn
            • with enlargment of ventricles - P52.21 Intraventricular (nontraumatic) hemorrhage, grade 3, of newborn
          • without intraventricular extension - P52.0 Intraventricular (nontraumatic) hemorrhage, grade 1, of newborn
      • hypoxic ischemic encephalopathy [HIE] - P91.60 Hypoxic ischemic encephalopathy [HIE], unspecified
        • mild - P91.61 Mild hypoxic ischemic encephalopathy [HIE]
        • moderate - P91.62 Moderate hypoxic ischemic encephalopathy [HIE]
        • severe - P91.63 Severe hypoxic ischemic encephalopathy [HIE]
      • induction of labor - P03.89 Newborn affected by other specified complications of labor and delivery
      • intestinal perforation - P78.0 Perinatal intestinal perforation
      • intrauterine (fetal) blood loss - P50.9 Newborn affected by intrauterine (fetal) blood loss, unspecified
        • due to (from)
          • cut end of co-twin cord - P50.5 Newborn affected by intrauterine (fetal) blood loss from cut end of co-twin's cord
          • hemorrhage into
            • co-twin - P50.3 Newborn affected by hemorrhage into co-twin
            • maternal circulation - P50.4 Newborn affected by hemorrhage into maternal circulation
          • placenta - P50.2 Newborn affected by intrauterine (fetal) blood loss from placenta
          • ruptured cord blood - P50.1 Newborn affected by intrauterine (fetal) blood loss from ruptured cord
          • vasa previa - P50.0 Newborn affected by intrauterine (fetal) blood loss from vasa previa
        • specified NEC - P50.8 Newborn affected by other intrauterine (fetal) blood loss
      • intrauterine (fetal) hemorrhage - P50.9 Newborn affected by intrauterine (fetal) blood loss, unspecified
      • intrauterine (in utero) procedure - P96.5 Complication to newborn due to (fetal) intrauterine procedure
      • malpresentation (malposition) NEC - P03.1 Newborn affected by other malpresentation, malposition and disproportion during labor and delivery
      • maternal (complication of) (use of)
        • alcohol - P04.3 Newborn affected by maternal use of alcohol
        • amphetamines - P04.16 Newborn affected by maternal use of amphetamines
        • analgesia (maternal) - P04.0 Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and delivery
        • anesthesia (maternal) - P04.0 Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and delivery
        • anticonvulsants - P04.13 Newborn affected by maternal use of anticonvulsants
        • antidepressants - P04.15 Newborn affected by maternal use of antidepressants
        • antineoplastic chemotherapy - P04.11 Newborn affected by maternal antineoplastic chemotherapy
        • anxiolytics - P04.1A Newborn affected by maternal use of anxiolytics
        • blood loss - P02.1 Newborn affected by other forms of placental separation and hemorrhage
        • cannabis - P04.81 Newborn affected by maternal use of cannabis
        • circulatory disease - P00.3 Newborn affected by other maternal circulatory and respiratory diseases
        • condition - P00.9 Newborn affected by unspecified maternal condition
          • specified NEC - P00.89 Newborn affected by other maternal conditions
        • cytotoxic drugs - P04.12 Newborn affected by maternal cytotoxic drugs
        • delivery - P03.9 Newborn affected by complication of labor and delivery, unspecified
          • Cesarean - P03.4 Newborn affected by Cesarean delivery
          • forceps - P03.2 Newborn affected by forceps delivery
          • vacuum extractor - P03.3 Newborn affected by delivery by vacuum extractor [ventouse]
        • diabetes mellitus (pre-existing) - P70.1 Syndrome of infant of a diabetic mother
        • disorder - P00.9 Newborn affected by unspecified maternal condition
          • specified NEC - P00.89 Newborn affected by other maternal conditions
        • drugs (addictive) (illegal) NEC - P04.49 Newborn affected by maternal use of other drugs of addiction
        • ectopic pregnancy - P01.4 Newborn affected by ectopic pregnancy
        • gestational diabetes - P70.0 Syndrome of infant of mother with gestational diabetes
        • hemorrhage - P02.1 Newborn affected by other forms of placental separation and hemorrhage
        • hypertensive disorder - P00.0 Newborn affected by maternal hypertensive disorders
        • incompetent cervix - P01.0 Newborn affected by incompetent cervix
        • infectious disease - P00.2 Newborn affected by maternal infectious and parasitic diseases
        • injury - P00.5 Newborn affected by maternal injury
        • labor and delivery - P03.9 Newborn affected by complication of labor and delivery, unspecified
        • malpresentation before labor - P01.7 Newborn affected by malpresentation before labor
        • maternal death - P01.6 Newborn affected by maternal death
        • medical procedure - P00.7 Newborn affected by other medical procedures on mother, not elsewhere classified
        • medication - P04.19 Newborn affected by maternal use of unspecified medication
          • specified type NEC - P04.18 Newborn affected by other maternal medication
        • multiple pregnancy - P01.5 Newborn affected by multiple pregnancy
        • nutritional disorder - P00.4 Newborn affected by maternal nutritional disorders
        • oligohydramnios - P01.2 Newborn affected by oligohydramnios
        • opiates - P04.14 Newborn affected by maternal use of opiates
          • administered for procedures during pregnancy or labor and delivery - P04.0 Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and delivery
        • parasitic disease - P00.2 Newborn affected by maternal infectious and parasitic diseases
        • periodontal disease - P00.81 Newborn affected by periodontal disease in mother
        • placenta previa - P02.0 Newborn affected by placenta previa
        • polyhydramnios - P01.3 Newborn affected by polyhydramnios
        • precipitate delivery - P03.5 Newborn affected by precipitate delivery
        • pregnancy - P01.9 Newborn affected by maternal complication of pregnancy, unspecified
          • specified - P01.8 Newborn affected by other maternal complications of pregnancy
        • premature rupture of membranes - P01.1 Newborn affected by premature rupture of membranes
        • renal disease - P00.1 Newborn affected by maternal renal and urinary tract diseases
        • respiratory disease - P00.3 Newborn affected by other maternal circulatory and respiratory diseases
        • sedative-hypnotics - P04.17 Newborn affected by maternal use of sedative-hypnotics
        • surgical procedure - P00.6 Newborn affected by surgical procedure on mother
        • tranquilizers administered for procedures during pregnancy or labor and delivery - P04.0 Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and delivery
        • urinary tract disease - P00.1 Newborn affected by maternal renal and urinary tract diseases
        • uterine contraction (abnormal) - P03.6 Newborn affected by abnormal uterine contractions
      • meconium peritonitis - P78.0 Perinatal intestinal perforation
      • membrane abnormalities - P02.9 Newborn affected by abnormality of membranes, unspecified
        • specified NEC - P02.8 Newborn affected by other abnormalities of membranes
      • membranitis - P02.78 Newborn affected by other conditions from chorioamnionitis
      • methamphetamine (s) - P04.49 Newborn affected by maternal use of other drugs of addiction
      • mixed metabolic and respiratory acidosis - P84 Other problems with newborn
      • neonatal abstinence syndrome - P96.1 Neonatal withdrawal symptoms from maternal use of drugs of addiction
      • noxious substances transmitted via placenta or breast milk - P04.9 Newborn affected by maternal noxious substance, unspecified
        • cannabis - P04.81 Newborn affected by maternal use of cannabis
        • specified NEC - P04.89 Newborn affected by other maternal noxious substances
      • nutritional supplements - P04.5 Newborn affected by maternal use of nutritional chemical substances
      • placenta previa - P02.0 Newborn affected by placenta previa
      • placental
        • abnormality (functional) (morphological) - P02.20 Newborn affected by unspecified morphological and functional abnormalities of placenta
          • specified NEC - P02.29 Newborn affected by other morphological and functional abnormalities of placenta
        • dysfunction - P02.29 Newborn affected by other morphological and functional abnormalities of placenta
        • infarction - P02.29 Newborn affected by other morphological and functional abnormalities of placenta
        • insufficiency - P02.29 Newborn affected by other morphological and functional abnormalities of placenta
        • separation NEC - P02.1 Newborn affected by other forms of placental separation and hemorrhage
        • transfusion syndromes - P02.3 Newborn affected by placental transfusion syndromes
      • placentitis - P02.78 Newborn affected by other conditions from chorioamnionitis
      • precipitate delivery - P03.5 Newborn affected by precipitate delivery
      • prolapsed cord - P02.4 Newborn affected by prolapsed cord
      • respiratory arrest - P28.81 Respiratory arrest of newborn
      • slow intrauterine growth - P05.9 Newborn affected by slow intrauterine growth, unspecified
      • tobacco - P04.2 Newborn affected by maternal use of tobacco
      • twin to twin transplacental transfusion - P02.3 Newborn affected by placental transfusion syndromes
      • umbilical cord (tightly) around neck - P02.5 Newborn affected by other compression of umbilical cord
      • umbilical cord condition - P02.60 Newborn affected by unspecified conditions of umbilical cord
        • short cord - P02.69 Newborn affected by other conditions of umbilical cord
        • specified NEC - P02.69 Newborn affected by other conditions of umbilical cord
      • uterine contractions (abnormal) - P03.6 Newborn affected by abnormal uterine contractions
      • vasa previa - P02.69 Newborn affected by other conditions of umbilical cord
        • from intrauterine blood loss - P50.0 Newborn affected by intrauterine (fetal) blood loss from vasa previa
    • apnea - P28.4 Other apnea of newborn
      • obstructive - P28.4 Other apnea of newborn
      • primary - P28.3 Primary sleep apnea of newborn
      • sleep (central) (obstructive) (primary) - P28.3 Primary sleep apnea of newborn
    • born in hospital - Z38.00 Single liveborn infant, delivered vaginally
      • by cesarean - Z38.01 Single liveborn infant, delivered by cesarean
    • born outside hospital - Z38.1 Single liveborn infant, born outside hospital
    • breast buds - P96.89 Other specified conditions originating in the perinatal period
    • breast engorgement - P83.4 Breast engorgement of newborn
    • check-up - See: Newborn, examination;
    • convulsion - P90 Convulsions of newborn
    • dehydration - P74.1 Dehydration of newborn
    • examination
      • 8 to 28 days old - Z00.111 Health examination for newborn 8 to 28 days old
      • under 8 days old - Z00.110 Health examination for newborn under 8 days old
    • fever - P81.9 Disturbance of temperature regulation of newborn, unspecified
      • environmentally-induced - P81.0 Environmental hyperthermia of newborn
    • hyperbilirubinemia - P59.9 Neonatal jaundice, unspecified
      • of prematurity - P59.0 Neonatal jaundice associated with preterm delivery
    • hypernatremia - P74.21 Hypernatremia of newborn
    • hyponatremia - P74.22 Hyponatremia of newborn
    • infection - P39.9 Infection specific to the perinatal period, unspecified
      • candidal - P37.5 Neonatal candidiasis
      • specified NEC - P39.8 Other specified infections specific to the perinatal period
      • urinary tract - P39.3 Neonatal urinary tract infection
    • jaundice - P59.9 Neonatal jaundice, unspecified
      • due to
        • breast milk inhibitor - P59.3 Neonatal jaundice from breast milk inhibitor
        • hepatocellular damage - P59.20 Neonatal jaundice from unspecified hepatocellular damage
          • specified NEC - P59.29 Neonatal jaundice from other hepatocellular damage
        • preterm delivery - P59.0 Neonatal jaundice associated with preterm delivery
      • of prematurity - P59.0 Neonatal jaundice associated with preterm delivery
      • specified NEC - P59.8 Neonatal jaundice from other specified causes
    • late metabolic acidosis - P74.0 Late metabolic acidosis of newborn
    • mastitis - P39.0 Neonatal infective mastitis
      • infective - P39.0 Neonatal infective mastitis
      • noninfective - P83.4 Breast engorgement of newborn
    • multiple born NEC - Z38.8 Other multiple liveborn infant, unspecified as to place of birth
      • born in hospital - Z38.68 Other multiple liveborn infant, delivered vaginally
        • by cesarean - Z38.69 Other multiple liveborn infant, delivered by cesarean
      • born outside hospital - Z38.7 Other multiple liveborn infant, born outside hospital
    • omphalitis - P38.9 Omphalitis without hemorrhage
      • with mild hemorrhage - P38.1 Omphalitis with mild hemorrhage
      • without hemorrhage - P38.9 Omphalitis without hemorrhage
    • post-term - P08.21 Post-term newborn
    • prolonged gestation (over 42 completed weeks) - P08.22 Prolonged gestation of newborn
    • quadruplet - Z38.8 Other multiple liveborn infant, unspecified as to place of birth
      • born in hospital - Z38.63 Quadruplet liveborn infant, delivered vaginally
        • by cesarean - Z38.64 Quadruplet liveborn infant, delivered by cesarean
      • born outside hospital - Z38.7 Other multiple liveborn infant, born outside hospital
    • quintuplet - Z38.8 Other multiple liveborn infant, unspecified as to place of birth
      • born in hospital - Z38.65 Quintuplet liveborn infant, delivered vaginally
        • by cesarean - Z38.66 Quintuplet liveborn infant, delivered by cesarean
      • born outside hospital - Z38.7 Other multiple liveborn infant, born outside hospital
    • seizure - P90 Convulsions of newborn
    • sepsis (congenital) - P36.9 Bacterial sepsis of newborn, unspecified
      • due to
        • anaerobes NEC - P36.5 Sepsis of newborn due to anaerobes
        • Escherichia coli - P36.4 Sepsis of newborn due to Escherichia coli
        • Staphylococcus - P36.30 Sepsis of newborn due to unspecified staphylococci
          • aureus - P36.2 Sepsis of newborn due to Staphylococcus aureus
          • specified NEC - P36.39 Sepsis of newborn due to other staphylococci
        • Streptococcus - P36.10 Sepsis of newborn due to unspecified streptococci
          • group B - P36.0 Sepsis of newborn due to streptococcus, group B
          • specified NEC - P36.19 Sepsis of newborn due to other streptococci
      • specified NEC - P36.8 Other bacterial sepsis of newborn
    • triplet - Z38.8 Other multiple liveborn infant, unspecified as to place of birth
      • born in hospital - Z38.61 Triplet liveborn infant, delivered vaginally
        • by cesarean - Z38.62 Triplet liveborn infant, delivered by cesarean
      • born outside hospital - Z38.7 Other multiple liveborn infant, born outside hospital
    • twin - Z38.5 Twin liveborn infant, unspecified as to place of birth
      • born in hospital - Z38.30 Twin liveborn infant, delivered vaginally
        • by cesarean - Z38.31 Twin liveborn infant, delivered by cesarean
      • born outside hospital - Z38.4 Twin liveborn infant, born outside hospital
    • vomiting - P92.09 Other vomiting of newborn
      • bilious - P92.01 Bilious vomiting of newborn
    • weight check - Z00.111 Health examination for newborn 8 to 28 days old

Footnotes

Amphetamines: Analogs or derivatives of AMPHETAMINE. Many are sympathomimetics and central nervous system stimulators causing excitation, vasopressin, bronchodilation, and to varying degrees, anorexia, analepsis, nasal decongestion, and some smooth muscle relaxation.

Anticonvulsants: Drugs used to prevent SEIZURES or reduce their severity.

Anti-Anxiety Agents: Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here.

Apnea: A transient absence of spontaneous respiration.

Bradycardia: Cardiac arrhythmias that are characterized by excessively slow HEART RATE, usually below 50 beats per minute in human adults. They can be classified broadly into SINOATRIAL NODE dysfunction and ATRIOVENTRICULAR BLOCK.

Cannabis: The plant genus in the Cannabaceae plant family, Urticales order, Hamamelidae subclass. The flowering tops are called many slang terms including pot, marijuana, hashish, bhang, and ganja. The stem is an important source of hemp fiber.

Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).

Cerebral Cortex: The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulchi. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions.

Cocaine: An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake.

Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or "seizure disorder."

Dehydration: The condition that results from excessive loss of water from a living organism.

Escherichia coli: A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc.

Fever: An abnormal elevation of body temperature, usually as a result of a pathologic process.

Hallucinogens: Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise.

Hemorrhage: Bleeding or escape of blood from a vessel.

Hyperbilirubinemia: A condition characterized by an abnormal increase of BILIRUBIN in the blood, which may result in JAUNDICE. Bilirubin, a breakdown product of HEME, is normally excreted in the BILE or further catabolized before excretion in the urine.

Hypernatremia: Excessive amount of sodium in the blood. (Dorland, 27th ed)

Hyponatremia: Deficiency of sodium in the blood; salt depletion. (Dorland, 27th ed)

Infarction: Formation of an infarct, which is NECROSIS in tissue due to local ISCHEMIA resulting from obstruction of BLOOD CIRCULATION, most commonly by a THROMBUS or EMBOLUS.

Infection: Invasion of the host organism by microorganisms that can cause pathological conditions or diseases.

Communicable Diseases: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.

Wounds and Injuries: Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity.

Jaundice: A clinical manifestation of HYPERBILIRUBINEMIA, characterized by the yellowish staining of the SKIN; MUCOUS MEMBRANE; and SCLERA. Clinical jaundice usually is a sign of LIVER dysfunction.

Mastitis: INFLAMMATION of the BREAST, or MAMMARY GLAND.

Maternal Death: The death of the female parent.

Pregnancy, Multiple: The condition of carrying two or more FETUSES simultaneously.

Neonatal Abstinence Syndrome: Fetal and neonatal addiction and withdrawal as a result of the mother's dependence on drugs during pregnancy. Withdrawal or abstinence symptoms develop shortly after birth. Symptoms exhibited are loud, high-pitched crying, sweating, yawning and gastrointestinal disturbances.

Oligohydramnios: A condition of abnormally low AMNIOTIC FLUID volume. Principal causes include malformations of fetal URINARY TRACT; FETAL GROWTH RETARDATION; GESTATIONAL HYPERTENSION; nicotine poisoning; and PROLONGED PREGNANCY.

Opiate Alkaloids: Alkaloids found in OPIUM from PAPAVER and their derivatives that induce analgesic and narcotic effects by action upon OPIOID RECEPTORS.

Parasitic Diseases: Infections or infestations with PARASITES. They are often contracted through contact with an intermediate vector, but may occur as the result of direct exposure.

Periodontal Diseases: Pathological processes involving the PERIODONTIUM including the gum (GINGIVA), the alveolar bone (ALVEOLAR PROCESS), the DENTAL CEMENTUM, and the PERIODONTAL LIGAMENT.

Placenta: A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES).

Polyhydramnios: A condition of abnormally high AMNIOTIC FLUID volume, such as greater than 2,000 ml in the LAST TRIMESTER and usually diagnosed by ultrasonographic criteria (AMNIOTIC FLUID INDEX). It is associated with maternal DIABETES MELLITUS; MULTIPLE PREGNANCY; CHROMOSOMAL DISORDERS; and congenital abnormalities.

Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.

Quadruplets: Four individuals derived from four FETUSES that were fertilized at or about the same time, developed in the UTERUS simultaneously, and born to the same mother.

Quintuplets: Five individuals derived from five FETUSES that were fertilized at or about the same time, developed in the UTERUS simultaneously, and born to the same mother.

Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or "seizure disorder."

Staphylococcus: A genus of gram-positive, facultatively anaerobic, coccoid bacteria. Its organisms occur singly, in pairs, and in tetrads and characteristically divide in more than one plane to form irregular clusters. Natural populations of Staphylococcus are found on the skin and mucous membranes of warm-blooded animals. Some species are opportunistic pathogens of humans and animals.

Streptococcus: A genus of gram-positive, coccoid bacteria whose organisms occur in pairs or chains. No endospores are produced. Many species exist as commensals or parasites on man or animals with some being highly pathogenic. A few species are saprophytes and occur in the natural environment.

Tachycardia: Abnormally rapid heartbeat, usually with a HEART RATE above 100 beats per minute for adults. Tachycardia accompanied by disturbance in the cardiac depolarization (cardiac arrhythmia) is called tachyarrhythmia.

Tobacco: A plant genus of the family SOLANACEAE. Members contain NICOTINE and other biologically active chemicals; its dried leaves are used for SMOKING.

Triplets: Three individuals derived from three FETUSES that were fertilized at or about the same time, developed in the UTERUS simultaneously, and born to the same mother.

Twins: Two individuals derived from two FETUSES that were fertilized at or about the same time, developed in the UTERUS simultaneously, and born to the same mother. Twins are either monozygotic (TWINS, MONOZYGOTIC) or dizygotic (TWINS, DIZYGOTIC).

Urinary Tract: The duct which coveys URINE from the pelvis of the KIDNEY through the URETERS, BLADDER, and URETHRA.

Vomiting: The forcible expulsion of the contents of the STOMACH through the MOUTH.

Previous Term
Nevus